The influence of salt (sodium chloride; NaCl) (an additional 6% in the diet) and that of a novel sodium-reduced, potassium-, magnesium-, and L-lysine-enriched salt alternative on the cardiovascular effects of ramipril was studied in stroke-prone spontaneously hypertensive rats in a 6-week study. The intake of sodium chloride was adjusted to the same level by adding the salt alternative at a 1.75 times higher amount than regular salt. 2 Salt produced a marked rise in blood pressure and induced cardiac hypertrophy and significant mortality, while the salt alternative neither increased blood pressure nor caused any mortality and produced less cardiac hypertrophy than salt. 3 Ramipril treatment at a daily dose of 3 mg kg' normalized blood pressure and prevented the development of cardiac hypertrophy of rats on control diet. These effects of ramipril were blocked by the addition of salt but were only slightly attenuated by the addition of the salt alternative. The mortality in -the salt group was prevented by ramipril. 4 Responses of mesenteric arterial rings in vitro were examined at the end of the study. Salt, but not the salt alternative, increased vascular contractile responses to noradrenaline. Ramipril treatment improved the arterial relaxation responses to acetylcholine and to sodium nitroprusside. The vascular relaxation enhancing effect of ramipril was blocked by salt but only slightly attenuated by the salt alternative. 5 Ramipril treatment did not significantly increase plasma renin activity in the presence or in the absence of salt supplementation. The salt alternative did not cause hyperkalaemia, either alone or in combination with ramipril treatment. 6 Both salt supplementations, irrespective of ramipril treatment, induced a six to eight fold increase in the urinary excretion of calcium. There was an expected 90 to 140% rise in the urinary excretion of magnesium and 200% rise in the urinary excretion of potassium in the salt alternative group. Salt also produced an approximately 50% increase in magnesuria. 7 Our findings suggest that replacement of salt by the potassium-, magnesium-and L-lysine-enriched salt alternative improves the cardiovascular effects of ramipril. In the present study the beneficial effect was related to the increased intakes of potassium and/or magnesium and L-lysine from the salt alternative because the amount of sodium chloride was the same.
Introduction
Angiotensin-converting enzyme inhibitors (ACEIs) belong in many countries to the first-line drugs in the treatment of arterial hypertension and congestive heart failure. Unfortunately, the high sodium chloride (salt) intake, typical for most industrialized societies (Law et al., 1991a) , interferes with the therapeutic effects of ACEIs. Therefore, salt restriction or natriuretic diuretics are frequently used to improve the therapeutic efficacy of ACEIs (Waeber et al., 1990) .
Even without drug treatment, reduction in the intake of sodium chloride has an antihypertensive effect (Jula et al., 1990; Frost et al., 1991; Law et al., 1991a,b) . Moreover, recent evidence indicates that potassium supplementation produces natriuresis (Young et al., 1976) , lowers blood pressure (Cappucio & MacGregor, 1991) and protects against stroke (Khaw & Barrett-Connor, 1986; Tobian, 1988) . Increased intake of magnesium may also, in some cases, reduce Author for correspondence. blood pressure and produce a variety of other favourable cardiovascular and metabolic effects (Sjbgren et al., 1989; Altura & Altura, 1990; Karppanen, 1990; Lind et al., 1991) . In agreement with these observations we have recently found that, unlike normal salt, a novel potassium-, magnesium-, and L-lysine-enriched salt alternative, even in high doses did not raise blood pressure and produced little if any left ventricular hypertrophy in the spontaneously hypertensive rats (SHR) (Mervaala et al., 1992) . In experimental hypertension, the endothelium-dependent relaxation of vascular smooth muscle is impaired (Konishi & Su, 1983; LUischer et al., 1987; Tesfamariam & Halperin, 1988) . Moreover, high sodium chloride diet and severe hypertension in the stroke-prone SHR induce injury to endothelial cells (Tobian, 1988) , and a high potassium diet protects against the salt-induced endothelial dysfunction (Sugimoto et al., 1988) . ACEI treatment improves the endothelium-dependent vascular relaxation in SHR by increasing the production of endothelium-derived relaxing factor(s) and by preventing the de-gradation of bradykinin liberated from the endothelial cells (Clozel et al., 1990; Wiemer et al., 1991; Arvola et al., 1993) . In experimental and clinical studies, ACEIs reduce cardiac hypertrophy in antihypertensive doses (Waeber et al., 1990) . Ramipril is able to prevent the left ventricular hypertrophy even in non-antihypertensive doses in rats made hypertensive by aortic ligation (Linz et al., 1992) .
In the present six-week study we compared the influence of the novel potassium-and magnesium-enriched salt alternative with that of normal salt on the cardiovascular effects of the ACEI ramipril in stroke-prone SHR. The effects of long-term angiotensin-converting enzyme inhibition and those of longterm salt supplementations on arterial functions were estimated by responses of the mesenteric arterial rings in vitro. In addition, we tried to elucidate the safety profile of the salt alternative by measuring the plasma electrolyte levels. In particular, we were interested in examining whether the moderate increase in the intake of potassium from the salt alternative, in combination with the ramipril treatment, increases the risk of hyperkalaemia.
Methods
Experimental animals and diets Sixty inbred male stroke-prone spontaneously hypertensive rats (SHRSP), originally developed by Okamoto et al. (1974) , were used. The rats from our breeding were housed five animals in a cage in an animal laboratory (illuminated from 06 h 30 min to 18 h 30 min, room temperature 22-24°C). At the beginning of the study, the nine-week-old rats were randomized into six subgroups to receive different diet and drug regimens for six weeks. The NaCl-enriched diet was produced by adding 6.0 g of NaCl to 94.0 g of the standard rat chow (Finnewos Aqua, Helsinki, Finland) . The salt alternative enriched diet was produced by adding 10.5 g of the commercially available salt alternative Pansalt, (Oriola Oy, Espoo, Finland) , to 89.5 g of the chow. This salt alternative has the following composition: NaCl 57%, KCl 28%, MgSO4-7H20 12%, L-lysine hydrochloride 2% and anticaking agents (MgCO3, SiO2) 1%. Hence, sodium chloride was adjusted to the same level in the NaCl-enriched and in the salt alternative-enriched chows. The contents of sodium, potassium, magnesium and other nutrients in the different diets are given in Table 1 . The rats had free access to tap water and chow. Ramipril was added to the pellets (35 mg ramipril kg ' dry weight of the pellets) to produce an approximate daily dose of 3 mg kg-' body weight. Systolic blood pressure of the pretrained rats was measured weekly by a tail cuff method (Blood pressure recorder, model no. 8002e, W + W electronics Inc., Basel, Switzerland) as described in detail earlier (Mervaala et al., 1992) . The animals were examined daily for survival and signs of stroke throughout the study. Assessment of stroke was based on the presence of evident and stable hemiplegia, akinesia, lethargy, and hyporesponsiveness according to the symptomatological classification described by Yamori et al. (1982) . During the fifth week of the experiment the rats were housed individually in metabolic cages. Food intake was recorded and urine was collected over a 24-h period. After the six-week experimental period, the rats were anaesthetized with sodium pentobarbitone (65 mg kg-', i.p.), the carotid artery was cannulated and blood samples were taken into two chilled tubes on ice using EDTA (4.5 mM) and heparin (100 units ml-') as anticoagulants. The hearts were excised, great vessels, atria and the free wall of the right ventricle were dissected and the left ventricular mass (LVM) was measured. The left ventricular Figure 1 Line plots show blood pressure in stroke-prone spontaneously hypertensive rats (SHRSP) during different diet and drug regimens: (0) controls on normal diet (n = 10); (0) supplementation with salt (NaCl) (n = 7-10); (A) supplementation with the salt alternative (ni= 10); (0) ramipril during control diet (n-=l1); (U) ramipril during NaCl-enriched diet (n = 10); (A) ramipril during salt alternative-enriched diet (ni= 10). Repeated analysis of variance between-subjects effects, P<0.0001; within-subject effects, P<O.0001; time-group interaction, P<0.0001. NaCl-enriched diet produced a rise in blood pressure (P<0.01 to 0.001 versus all other groups). Ramipril treatment (3 mg kg-' day-') during control and salt alternative-enriched diets significantly decreased blood pressure (P<0.001 versus all other groups). Symbols indicate means with s.e.mean.
Determination ofplasma renin activity Plasma renin activity was determined by use of a radioimmunoassay (RIA) of angiotensin I, modified for rat plasma (Tikkanen et al., 1980) .
Determination of electrolyte concentrations
The concentrations of the elements, sodium, potassium, phosphorus, magnesium, calcium and zinc in urine were determined by using Baird PS-4 inductively-coupled plasma emission spectrometer (Baird Co, Bedford, MA, U.S.A.) as described in detail elsewhere (Laakso et al., 1991) . The intraassay imprecision for the elements was better than 3% and the inter-assay imprecision was not more than 5%. For magnesium the intra-assay imprecision was 1.5% and the inter-assay imprecision was 0.5%. The mean levels obtained for the NIST (National Institute of Standards, Washington, U.S.A.) 1 577b reference material were within 3.5% of NIST certified values. The concentrations of sodium and potassium in plasma were determined by a standard ion selective electrode method employing a Cobas Fara II random access analyzer (F. Hoffman-La Roche, Basel, Switzerland) according to the instructions of the manufacturer. The concentration of magnesium in plasma was determined with a spectroscopic method using metallochromic dye, Camalgite (Sherwood Medical, St Louis, MO., U.S.A.), and the Cobas Fara II. Interassay imprecisions were 0.5%, 0.65% and 1.5%, for plasma sodium, potassium and magnesium respectively. Figure 2 Graph showing left ventricular hypertrophy index expressed as left ventricular wet weight (LVWW) -to-body weight (BW) ratio, of stroke-prone spontaneously hypertensive rats after six weeks on the different diet and drug regimens. C, controls on normal diet (n = 1O); Na, supplementation with salt (NaCl) (n = 7); SA, supplementation with the salt alternative (n = 10); RC, ramipril during control diet (n = 10); RNa, ramipril during NaCl-enriched diet (n = 10); RSA, ramipril during salt alternative-enriched diet (n = 10). 
Results
Death-rate and stroke Three of the 10 SHRSP which received the NaCI-enriched diet died during the experiment. All those three salt-loaded SHRSP suffered before death from clinically diagnosed stroke. By contrast, none of the SHRSP receiving the salt alternative-enriched diet died or suffered from stroke. In the group receiving ramipril treatment, no deaths occurred and there was no evidence of stroke in the SHRSP supplemented either with salt or the salt alternative. The mortality in the NaCl group without ramipril treatment was significant as compared to the other groups (mortality within 42 days, 2 x 2 Table, NaCl group versus other groups combined, Fisher exact two-tail test, P = 0.0035).
Blood pressure and left ventricular mass Enrichment of the diet with salt produced a marked further elevation of blood pressure as compared to the age-related increase in blood pressure of the SHRSP receiving control diet (Figure 1 ). The rats receiving the diet which was en- Noradrenaline (-log M) Figure 3 Contractile responses to noradrenaline of isolated endothelium-intact mesenteric arterial rings from the stroke-prone spontaneously hypertensive rats after six weeks on the different diet and drug regimens: (0) controls on normal diet; (0) supplementation with salt (NaCI); (A) supplementation with the salt alternative; (0) ramipril during control diet; (-) ramipril during NaCI-enriched diet; (A) ramipril during salt alternative-enriched diet. Repeated analysis of variance between-subjects effects, P = 0.027; within-subject effects, P< 0.0001; interaction, P = 0.0399. NaCI supplementation increased vascular response to noradrenaline (P <0.05 versus control group and ramipril-treated groups during control and the salt alternativeenriched diets). Symbols indicate means, n = 5-6 in each group. riched with the salt alternative showed no significant increase in blood pressure when compared to the control SHRSP. Ramipril treatment normalized blood pressure during control diet, markedly lowered blood pressure during the salt alternative-enriched diet, but did not significantly affect the rise of blood pressure during the NaCl-enriched diet (Figure 1 ). Salt produced left ventricular hypertrophy as indicated by a marked increase in the left ventricular wet weight-to-body weight ratio (Figure 2 ). In the salt alternative supplemented rats, the left ventricular hypertrophy index was increased when compared to the control group but lower as compared to the NaCl group. Ramipril treatment during control diet prevented the development of left ventricular hypertrophy. Ramipril treatment only partially blocked the left ventricular hypertrophy in the NaCl group. By contrast, in the ramipriltreated SHRSP of the salt alternative group the left ventricular hypertrophy index did not differ from that in the control SHRSP.
Mesenteric arterial responses in vivo
The vascular contractile responses to noradrenaline were increased in the NaCl group (Figure 3 ). No changes between the different groups were found in the vascular contractile (Figure 4) . Ramipril treatment during control and the salt alternative-enriched diets enhanced the vascular relaxation responses to acetylcholine ( Figure 5 ). In these groups, the first significant relaxation response to ACh was found at 10 nM ACh, while in the other groups equal relaxation was obtained at about ten fold higher ACh concentration. The maximal relaxation response to ACh (at 1-10 AM ACh concentration) was significantly greater in the ramipril-treated groups during control and the salt alternative-enriched diets (about 65-75% from maximum) as compared to those of the other groups (about 25-35% from maximum) (P<0.05-0.001). Ramipril treatment during control and the salt alternative-enriched diets enhanced the vascular relaxation responses to sodium nitroprusside ( Figure 6 ). The dose-response curves of these groups were shifted to the left, and the 90% relaxation response to SNP was obtained at 0.1 tIM SNP concentration. The equal relaxation was obtained at about 10 to 100 fold higher SNP concentrations in the other groups. There was no difference between different groups in the maximal relaxation response to SNP. If only ramipril-treated groups during control and the salt alternative-enriched diets were included in the statistical analysis, a slight but insignificant difference in the vascular relaxation responses to SNP was found (repeated ANOVA, P = 0.0995). Acetylcholine (-log M) Figure 5 Cumulative relaxation responses to acetylcholine of isolated endothelium-intact mesenteric arterial rings from the strokeprone spontaneously hypertensive rats after six weeks on the different diet and drug regimens: (0) controls on normal diet; (0) supplementation with salt (NaCI); (A) supplementation with the salt alternative; (0) ramipril during control diet; (U) ramipril during Sodium nitroprusside (-log M) Figure 6 Cumulative relaxation responses to sodium nitroprusside of isolated endothelium-intact mesenteric arterial rings from the stroke-prone spontaneously hypertensive rats after six weeks on the different diet and drug regimens: (0) controls on normal diet; (0) supplementation with salt (NaCI); (A) supplementation with the salt alternative; (0) ramipril during control diet; (U) ramipril during NaCl-enriched diet; (A) ramipril during salt alternative-enriched diet. Repeated analysis of variance between-subjects effects, PK 0.0001; within-subject effects, P<0.0001; interaction, P<0.0001.
Ramipril treatment improved relaxation responses to sodium nitroprusside during control diet (P<0.001 versus all ramipril-untreated groups and ramipril group during NaCl-enriched diet) and during the salt alternative-enriched diet (P<0.05-0.01 versus control group and NaCl groups with and without ramipril treatment). Symbols indicate means, n = 5-6 in each group.
Metabolic variables and indicators
At the end of the follow-up period, the body weights of NaCi-and salt alternative-supplemented rats were slightly decreased (repeated ANOVA between-subjects effects P= 0.0041; within-subject effects P<0.0001, time-group interaction P<0.0001; NaCl group versus control group and all ramipril-treated groups, P<0.05; salt alternative group versus ramipril group on control diet, P<0.05). There were no significant differences between the groups in the food intake after four weeks on the different diet and drug regimens ( Table 2 ). The ramipril group on control diet and all groups with salt supplements, in the presence or in the absence of ramipril, had an increased diuresis. The calculated average daily dose of ramipril was 2.8 ± 0.1, 2.6 ± 0.1 and 3.0 ± 0.2 mg kg-' body weight in the ramipril-treated rats on control, NaCI-enriched and the salt alternative-enriched diets, respectively (P = 0.2048).
Urine electrolytes
The 24 h urinary excretion of sodium was increased in all groups with salt supplements when compared to the control diet groups (Table 2) . Potassium excretion was increased in the salt alternative-supplemented rats both with and without ramipril. The excretion of magnesium was markedly increased in the salt alternative groups, and it was significantly increased even in the NaCl groups. There was a marked rise in the urinary excretion of calcium in all groups with salt supplements when compared to the control diet groups. The level of phosphorus in urine was increased in NaCl supplemented rats both with and without ramipril. The level of zinc in urine was markedly increased in the NaCl and in the salt alternative groups without ramipril treatment.
Plasma electrolytes and renin activity
There were no significant differences between the different groups in the plasma levels of sodium, potassium and magnesium, or in plasma renin activity (Table 3 ).
An increased intake of salt (sodium chloride; NaCl) produced a marked further elevation of blood pressure and increase in left ventricular hypertrophy as compared to the age-related increases in control SHRSP. The increased intake of sodium chloride also produced significant mortality of SHRSP during the six-week experiment. These effects of NaCI are in agreement with previous findings in SHR and SHRSP (Oparil et al., 1988; Tobian, 1988; Karppanen, 1989; Mervaala et al., 1992) . By contrast, the salt alternative, when added at 1.75 times higher amounts to produce the same dietary level of sodium chloride, neither caused any mortality nor induced any significant rise in blood pressure. It also caused significantly less left ventricular hypertrophy than NaCl. These results confirm our recent findings (Mervaala et al., 1992) . In our previous study the salt alternative prolonged the life span of SHR nearly three fold as compared with the animals receiving NaCl (Karppanen, 1989) .
Previous studies have suggested that the detrimental effects of a high intake of sodium chloride could have been mediated mainly by elevated blood volume and cardiac output and by elevated sympathetic nervous system activity (Muntzel & Drueke, 1992) . Normalization of sodium and water balance and sympathetic nervous activity appeared to explain, at least in part, the protection against the harmful effects of the increased intake of sodium chloride by the increased intakes of potassium and/or magnesium and Llysine from the salt alternative (Karppanen, 1989; Mervaala et al., 1992) .
In experimental and clinical studies ACEIs have been demonstrated to be effective in the treatment of cardiac hypertrophy when used at antihypertensive doses (Waeber et al., 1990) . In the present study, consistent with previous work (Unger et al., 1984) , chronic treatment of SHRSP with ramipril at an approximate daily dose of 3 mg kg-' normalized blood pressure and prevented the development of left ventricular hypertrophy during a relatively low-sodium control diet. Reduction of myocardial tissue angiotensin II by Table 2 Twenty-four hour food consumption, urine volume and urinary excretion rates of various mineral elements of stroke-prone spontaneously hypertensive rats after four weeks on the different diet and drug regimens The control group (C, n = 10) and the ramipril group (RC, n = 10; ramipril mixed in the chow to produce an approximate daily dose of 3 mg kg-') received standard rat chow (Na 0.3%). The chow of the high sodium chloride group (Na, n = 10) and that of the high sodium chloride + ramipril group (RNa, n = 10; ramipril as above) was supplemented with salt (6% sodium chloride). The chow of the salt alternative group (SA, n = 10) and that of the salt alternative + ramipril group (RSA, n = 10; ramipril as above) was supplemented with 10.5% of the salt alternative (Pansalt). The control group (C, n = 10) and the ramipril group (RC, n = 10; ramipril mixed in the chow to produce an approximate daily dose of 3 mg kg-') received standard rat chow (Na 0.3%). The chow of the high sodium chloride group (Na, n = 10) and that of the high sodium chloride + ramipril group (RNa, n = 10; ramipril as above) was supplemented with salt (6% sodium chloride). The chow of the salt alternative group (SA, n = 10) and that of the salt alternative + ramipril group (RSA, n = 10; ramipril as above) was supplemented with 10.5% of the salt alternative (Pansalt).
chronic treatment with ACEI in SHR has been reported (Nagano et al., 1991) . There is much evidence to suggest that angiotensin II is involved in the production of myocardial (Pfeffer et al., 1982; Hall & Karlberg, 1986; Clozel et al., 1989; Childs et al., 1990; Schunkert et al., 1990; Brilla et al., 1991; Lindpaintner & Ganten, 1991) and vascular wall hypertrophy (Kato et al., 1991) . ACE inhibition increases the levels of bradykinin which appears to give protection against the development of cardiovascular hypertrophy (Wiemer et al., 1991) .
Ramipril treatment did not produce any significant lowering in blood pressure, and it only partially protected against the development of left ventricular hypertrophy, in SHRSP receiving the NaCl-enriched diet. However, in spite of the lack of effect on these cardiovascular variables, ramipril protected against stroke and mortality. In agreement with our observation, Stier et al. (1989) also found that, during a high intake of sodium chloride, ACEI treatment decreased SHRSP mortality. The mechanism of this protective effect of ACEI is not clear.
In spite of the high intake of sodium chloride, ramipril produced a remarkable antihypertensive effect in SHRSP receiving the salt alternative-enriched diet, and it protected against stroke and mortality. In addition, during the salt alternative-enriched diet ramipril protected against the development of sodium chloride-induced cardiac hypertrophy. Hence, increased intakes of potassium and/or magnesium and L-lysine during a high intake of sodium chloride improved the beneficial effects of ramipril. It has been suggested that ramipril treatment might increase the risk of hyperkalaemia, at least in patients taking supplemental potassium or a potassium-sparing diuretic (Waeber et al., 1990) . However, the present salt alternative did not cause any tendency to hyperkalaemia, either alone or in combination with ramipril treatment.
The inhibitory effect of a high intake of sodium chloride on the antihypertensive effect of ACEI is consistent with previous observations (Fernandez et al., 1988; Waeber et al., 1990) . It has been suggested that the resistance towards the effects of ACEI results from salt-induced inhibition in the activity of the renin-angiotensin-aldosterone system (Waeber et al., 1990) . In the present study increased intake of potassium and/or magnesium and L-lysine from the salt alternative counteracted the inhibitory effect of high intake of sodium chloride on the cardiovascular effects of ramipril. However, neither in the NaCl nor in the salt alternative supplemented SHRSP did the increased intake of sodium chloride affect plasma renin activity (PRA). Furthermore, in the presence of ramipril treatment PRA was only slightly and insignificantly increased. Hence, PRA does not appear to explain the marked improvement of the effects of ramipril by the salt alternative in comparison to NaCl.
Previous studies have shown that, in experimental hypertension, the endothelium-dependent relaxation of vascular smooth muscle is impaired (Konishi & Su, 1983; Luscher et al., 1987; Tesfamariam & Halperin, 1988) . Arvola et al. (1993) recently demonstrated that quinapril treatment improved the endothelium-dependent vascular relaxation of SHR. The ACEI treatment has been shown to improve the endothelium-dependent vascular relaxation in SHR by increasing the production of endothelium-derived relaxing factor(s) and by preventing the degradation of bradykinin liberated from the endothelial cells (Clozel et al., 1990; Wiemer et al., 1991; Arvola et al., 1993) . In the present study the effects of long-term angiotensin-converting enzyme inhibition and those of long-term salt supplementations on arterial functions were estimated by responses of the mesenteric arterial rings in vitro. Supplementation with NaCI, but not that with the salt alternative, increased vascular contractile responses to noradrenaline. Ramipril treatment improved the arterial relaxation responses to acetylcholine as well as to sodium nitroprusside, suggesting the involvement of both endothelium-dependent and endothelium-independent mechanisms. This could partly result from normalization of blood pressure in the ramipril-treated SHR and thus from better preservation of the endothelial functions during the six-week study. Consistent with our findings Arvola et al. (1993) have shown that, in SHR, ACE treatment improves the vascular relaxation responses to three different types of vasorelaxants (to acetylcholine, nitroprusside and isoprenaline). They have suggested that the augmentation of the endothelium-dependent and endothelium-independent vascular relaxation responses by ACEI treatment can be explained, at least in part, by improved cellular calcium regulation. In the present study the vascular relaxation enhancing effects of ramipril were blocked by NaCl supplementation. However, during the salt alternative-enriched diet the vascular relaxation enhancing effects of ramipril were only slightly attenuated. The observed changes in vascular reactivity may partly explain the hypertensive effect of sodium chloride and the beneficial effects of potassium, magnesium and L-lysine.
Supplementation of SHRSP with NaCl or the salt alternative produced a six to eight fold increase in the urinary calcium excretion, both in the absence and in the presence of ramipril treatment. This finding confirms the results of previous studies demonstrating a rise in urinary calcium excretion with increasing intake of sodium chloride both in man and animals (Shortt & Flynn, 1990) . Since the calciuric effect was similar in the NaCl and the salt alternative supplemented groups, it neither explains the markedly different cardiovas-C cular effects of NaCI and the salt alternative, nor the remarkable difference in the ramipril-induced cardiovascular effects between the groups. However, our finding lends further support to the suggestion that a high intake of sodium chloride may contribute to the development of osteoporosis (Shortt & Flynn, 1990) . The increase in urinary excretion of phosphorus by increased intake of sodium chloride may explain the fall in serum phosphate levels, observed by Altura & Altura (1991 in rats with malignant salt-induced hypertension. Interestingly, rats given magnesium exhibited restoration of phosphate to normal levels (Altura & Altura, 1991 . In agreement with this, in our study the excretion of phosphorus was not significantly increased in the rats receiving the magnesium-containing salt alternative. Consistently with previous studies (Wallach & Verch, 1986 ) a high intake of sodium chloride increased the urinary excretion of magnesium.
In conclusion, the present sodium-reduced, potassium-and magnesium-enriched salt alternative was virtually devoid of the hypertensive and cardiac hypertrophy producing effects, typical of NaCl. Replacement of salt in the diet by the salt alternative remarkably improved the cardiovascular effects of ramipril. This effect was due to increased intake of potassium and/or magnesium and L-lysine. The present salt alternative with moderate content of potassium did not produce any tendency to hyperkalaemia, even when combined with ACEI treatment.
